This study investigates the link between ubiquitin‐specific peptidase 9 X‐linked (USP9X) and Alzheimer's disease (AD) pathogenesis, aiming to identify potential targets for AD diagnosis, treatment, and drug development. The gene discussed is USP9X; the disease is early-onset autosomal dominant Alzheimer disease.